Exit Wealth Advisors »

Supernus Pharmaceuticals shares owned by Exit Wealth Advisors

Quarter-by-quarter ownership of Supernus Pharmaceuticals (SUPN) shares owned by Exit Wealth Advisors from 13F filings

Historical chart of Exit Wealth Advisors investment in Supernus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Supernus Pharmaceuticals held by Exit Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Supernus Pharmaceuticals by Exit Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $430k 8.7k 49.70

More positions owned by Exit Wealth Advisors

Spdr Series Trust State Street Spd (BIL)
Tesla Motors (TSLA)
Ishares Gold Tr Ishares New (IAU)
Microsoft Corporation (MSFT)
Wisdomtree Tr Floatng Rat Trea (USFR)
Apple (AAPL)
Ishares Silver Tr Ishares (SLV)
NVIDIA Corporation (NVDA)
Grayscale Bitcoin Mini Tr Et Shs New (BTC)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Ishares Tr Latn Amer 40 Etf (ILF)
Sprott Asset Management Physical Silver (PSLV)
Altria (MO)
Bitwise 10 Crypto Index Etf Unit Beneficial (BITW)

View all positions for Exit Wealth Advisors

Top funds holding Supernus Pharmaceuticals

BlackRock
Vanguard Group
Armistice Capital
Dimensional Fund Advisors
Point72 Asset Management
State Street Corporation
Renaissance Technologies
Geode Capital Management
Loomis, Sayles and
Citadel Advisors
Stephens Investment Management Group
Jennifer Ranahan
D. E. Shaw & Co
Charles Schwab Investment Management
Goldman Sachs Group

View all funds holding Supernus Pharmaceuticals